TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma

Part of paid clinical trials in Bay City, Michigan.

Sponsor
Barbara Ann Karmanos Cancer Institute
Study ID
NCT07118202
Status
Recruiting
Apply to this trial

Conditions

  • Hepatocellular Carcinoma Recurrent

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • TheraBionic P1 — DEVICE
    Amplitude-modulated electromagnetic fields will be self-administered and given continuously to patients in three 60-minute treatments per day, administered in the morning, middle of the day, and in the evening

Study Details

The goal of this clinical trial is to learn if the TheraBionic P1 device given to patients with advanced hepatocellular carcinoma (HCC) who have no standard of care options can affect patients survival. The main questions it aims to answer are: * will the TheraBionic P1 device affect overall survival in advance HCC * the long term safety and tolerability of the TheraBionic P1 device * assessment of how the disease responded to the TheraBionic P1 device

Key Dates

Start date
Oct 20, 2025
Status verified
Apr 2026
Primary completion
Aug 31, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
198 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: TheraBionic P1 device
    Self administered Amplitude-modulated electromagnetic fields three times daily

Primary Outcome Measure

Overall Survival [ Time Frame: From start of treatment until death, up to 24 months ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
Karmanos Cancer Institute at McLaren Bay RegionBay CityMichigan48706
1-989-667-2370
Karmanos Cancer InstituteDetroitMichigan48201
Anthonly F Shields, M.D.
[email protected]
313-576-8735
Karmanos Cancer Institute at McLaren FlintFlintMichigan48532
1-810-342-3800
Karmanos Cancer Institute at McLaren Greater LansingLansingMichigan48910
1-517-975-9500
Karmanos Cancer Institute at McLaren Lapeer RegionLapeerMichigan48446
810-667-4994
Karmanos Cancer Institute at McLaren Central Michigan, Morey Cancer CenterMount PleasantMichigan48858
1-989-772-6811

Find similar trials in Bay City, MI

By research site
Karmanos Cancer Institute at McLaren Bay Region· Bay City, MIKarmanos Cancer Institute· Detroit, MIKarmanos Cancer Institute at McLaren Flint· Flint, MIKarmanos Cancer Institute at McLaren Greater Lansing· Lansing, MIKarmanos Cancer Institute at McLaren Lapeer Region· Lapeer, MIKarmanos Cancer Institute at McLaren Central Michigan, Morey Cancer Center· Mount Pleasant, MI

Related Studies